Unraveling distinct intracellular signals that promote survival and proliferation: Study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells
St. Sawyer et Sm. Jacobs-helber, Unraveling distinct intracellular signals that promote survival and proliferation: Study of erythropoietin, stem cell factor, and constitutive signaling in leukemic cells, J HEMATH ST, 9(1), 2000, pp. 21-29
Citations number
65
Categorie Soggetti
Hematology,"Medical Research Diagnosis & Treatment
This review summarizes selected recent studies of the intracellular signals
that allow erythroid cells to survive and proliferate under the control of
erythropoietin (EPO) and alteration in signals that contribute to EPO-inde
pendent survival and proliferation. The hypothesis explored is that the pro
liferation and survival signals are distinct and can be separately studied
with the proper cell lines and growth factor stimulation. The anti- and pro
-apoptotic proteins Bcl-XL and BAD are highly implicated in EPO-dependent s
urvival of erythroid cells. Stat5 activity appears to be upstream of Bcl-XL
expression such that pathologic, constitutive activation of Stat5 may be a
common event in leukemic cells that become resistant to apoptosis by const
itutive expression of Bcl-XL. Other signals apparently also control the exp
ression of Bcl-XL, such as the expression of JunB which seem to be required
to suppress Bcl-XL expression when EPO is withdrawn. Apoptosis may also be
triggered by inactivation of Bcl-XL by BAD. Dephosphorylation of BAD as a
result of withdrawal of survival factors converts prosurvival BAD to proapo
ptotic BAD. Phosphorylation of BAD at the serine 112 residue seems critical
to promoting survival. Constitutive activation of a kinase that phosphoryl
ates BAD serine 112 may, therefore, contribute to resistance to apoptosis i
n leukemic cells. We describe the resistance of erythroleukemic cells to ap
optosis induced by EPO withdrawal apparently caused by constitutive BAD pho
sphorylation. The resistance to apoptosis in these cells is reversed by tre
atment with the PI3-kinase inhibitor, LY294002, suggesting that resistance
to apoptosis in these cells likely results from constitutive PI3-kinase tha
t is an upstream activator of an S-112 BAD kinase. The MAP kinase cascade i
s apparently active in EPO-dependent and stem cell factor (SCF)-dependent p
roliferation but not survival. In addition, autocrine tumor necrosis factor
-alpha (TNF-alpha) may also be a proliferation factor not affecting surviva
l. PI3-kinase seems to be required for full EPO-dependent proliferation but
is not required for EPO-dependent survival (but it can promote survival wh
en activated).